Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Cocaine Reinforcement
NCT01143857Phase 2Withdrawn
- Start
- Jun 2010
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine dependence comparing Varenicline with Placebo (2 arms). Primary endpoint: Varenicline's impact on reinforcing effects of cocaine at 6 weeks. Planned start Jun 2010; status: withdrawn.
02
Drugs
varenicline
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT01143857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143857.